Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel camphor-based ionic liquids enable high-yield esterification. Green synthesis route offers cost reduction and supply reliability for pharma intermediates.
Patent CN114920775B introduces a novel axial chiral bisindole catalyst offering high enantioselectivity and mild conditions for scalable pharmaceutical intermediate manufacturing.
Patent CN111777637B discloses a novel oxindole-derived phosphine catalyst enabling mild asymmetric cyclizations with excellent yields and supply chain stability.
Novel nitrogen-containing formyl catalyst method for sitagliptin intermediate. High yield, mild conditions, reduced costs for pharmaceutical manufacturing supply chains.
Advanced synthesis of spiro quaternary ammonium salts via kinetic resolution. Offers superior enantioselectivity for amino acid synthesis with scalable industrial processes.
Patent CN107936025B reveals a metal-free NHC catalytic route for high-purity chiral pyrazolidinones, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel synthesis method for high-purity chiral intermediates. Offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN101343263A reveals a green Mn(acac)3 catalyzed route for 5-nitro-4,5-dihydrofuran derivatives, offering high yields and simplified processing for reliable pharmaceutical intermediate suppliers.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN114920775B reveals high-selectivity catalyst synthesis. Offers cost reduction in pharmaceutical manufacturing and reliable supply chain solutions.
Patent CN113980044B reveals a novel Ir-O-P catalyzed diboration method. This breakthrough enables cost-effective, scalable production of high-purity organoboron intermediates for drug discovery.
Novel Rhodium-catalyzed oxidative coupling method enhances purity and reduces waste in API manufacturing, offering a reliable supply chain solution.
Discover novel axial chiral oxindole-derived styrene phosphine catalysts from patent CN111777637B. Enables asymmetric cyclization with mild conditions and scalable synthesis for fine chemical manufacturing.
Discover catalyst-free quinoline synthesis patent CN119330879B offering green manufacturing and supply chain reliability for pharmaceutical intermediates globally.
Discover advanced axial chiral styrene tertiary amine thiourea catalysts offering superior enantioselectivity and mild reaction conditions for pharmaceutical intermediate manufacturing.
Patent CN112916042B discloses a robust tetramethylspirodihydroindene catalyst enabling high enantioselectivity in glycine alkylations, offering cost-effective API manufacturing solutions.
Patent CN110452150B details a mild, one-step synthesis of axial chiral indole-naphthalenes with high enantioselectivity, offering cost-effective solutions for chiral catalyst manufacturing.
Patent CN105056991B reveals spirocyclic phosphazene catalysts enabling high ee asymmetric synthesis. Offers cost reduction and scalable supply for pharma intermediates.
Patent CN114456089B details a novel cobalt-catalyzed three-component reaction enabling efficient synthesis of amino-nitrile pharmaceutical intermediates with reduced costs.